Download presentation
Presentation is loading. Please wait.
1
Perfecting the ring and extending the antibacterial spectrum: ‘the multiple generations’
A. Bryskier Clinical Microbiology and Infection Volume 6, Pages (January 2000) DOI: /j tb02035.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
2
Figure 1 Discovery of cephalosporin C.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
3
Figure 2 Cephems: classification 2, chemical classification 1, modification of the ring. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
4
Figure 3 Cephems: classification 3, chemical classification 2, modification of substituents. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
5
Figure 4 Successive waves of cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
6
Figure 5 Cephems: microbiological classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
7
Figure 6 Cephems: pharmacokinetics classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
8
Figure 7 Cephems: classification: five subgroups A–E.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
9
Figure 8 Cephems group III.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
10
Figure 9 Cephem group III.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
11
Figure 10 Group III B cephems with long apparent elimination half-life. Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
12
Figure 11 Cephems: group III; Oxa-1-cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
13
Figure 12 Cephems zwitterionic compounds.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
14
Figure 13 Cephems: group IV (2) classification.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
15
Figure 14 Group IV C-3′ ammonium quaternary cephems.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
16
Figure 15 Cephems group IV: chemical alteration.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
17
Figure 16 Cephems: group V (2): classification
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
18
Figure 17 Cephems: group V.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
19
Figure 18 Cephems: group VII: cephems designed for anti-MRSA activity.
Clinical Microbiology and Infection 2000 6, 13-21DOI: ( /j tb02035.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.